 |
PDBsum entry 2qpf
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transport protein
|
PDB id
|
|
|
|
2qpf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transport protein
|
 |
|
Title:
|
 |
Crystal structure of mouse transthyretin
|
|
Structure:
|
 |
Transthyretin. Chain: a, b, c, d, e, f, g, h. Synonym: prealbumin. Engineered: yes
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Gene: ttr. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.05Å
|
R-factor:
|
0.200
|
R-free:
|
0.246
|
|
|
Authors:
|
 |
N.Reixach,T.R.Foss,E.Santelli,J.Pascual,J.W.Kelly,J.N.Buxbaum
|
Key ref:
|
 |
N.Reixach
et al.
(2008).
Human-Murine Transthyretin Heterotetramers Are Kinetically Stable and Non-amyloidogenic: A LESSON IN THE GENERATION OF TRANSGENIC MODELS OF DISEASES INVOLVING OLIGOMERIC PROTEINS.
J Biol Chem,
283,
2098-2107.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Jul-07
|
Release date:
|
27-Nov-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P07309
(TTHY_MOUSE) -
Transthyretin from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
147 a.a.
117 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
283:2098-2107
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Human-Murine Transthyretin Heterotetramers Are Kinetically Stable and Non-amyloidogenic: A LESSON IN THE GENERATION OF TRANSGENIC MODELS OF DISEASES INVOLVING OLIGOMERIC PROTEINS.
|
|
N.Reixach,
T.R.Foss,
E.Santelli,
J.Pascual,
J.W.Kelly,
J.N.Buxbaum.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The transthyretin amyloidoses appear to be caused by rate-limiting tetramer
dissociation and partial monomer unfolding of the human serum protein
transthyretin, resulting in aggregation and extracellular deposition of
amorphous aggregates and amyloid fibrils. Mice transgenic for few copies of
amyloid-prone human transthyretin variants, including the aggressive L55P
mutant, failed to develop deposits. Silencing the murine transthyretin gene in
the presence of the L55P human gene resulted in enhanced tissue deposition. To
test the hypothesis that the murine protein interacted with human transthyretin,
preventing the dissociation and partial unfolding required for amyloidogenesis,
we produced recombinant murine transthyretin and human/murine transthyretin
heterotetramers and compared their structures and biophysical properties to
recombinant human transthyretin. We found no significant differences between the
crystal structures of murine and human homotetramers. Murine transthyretin is
not amyloidogenic because the native homotetramer is kinetically stable under
physiologic conditions and cannot dissociate into partially unfolded monomers,
the misfolding and aggregation precursor. Heterotetramers composed of murine and
human subunits are also kinetically stable. These observations explain the lack
of transthyretin deposition in transgenics carrying a low copy number of human
transthyretin genes. The incorporation of mouse subunits into tetramers
otherwise composed of human amyloid-prone transthyretin subunits imposes kinetic
stability, preventing dissociation and subsequent amyloidogenesis.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIGURE 1. A, primary structure alignment of Hu-TTR and
Mu-TTR. Stars at the bottom indicate identical amino acid
residues. B, two views of the crystal structure of Mu-TTR
superimposed on that of Hu-TTR. Each mouse TTR subunit is shown
in a different color; Hu-TTR is shown in gray. Dashed lines
indicate the dimer interfaces, and the crystallographic C[2] x
axis is labeled.
|
 |
Figure 4.
FIGURE 4. Kinetics of tetramer disassembly (closed symbols)
and unfolding (open symbols) in 6 M urea for Hu-TTR (triangles)
and Mu-TTR (circles). For both Hu-TTR and Mu-TTR the loss of
quaternary structure (disassembly) and the loss of tertiary
structure (unfolding) are tightly linked. Mu-TTR is kinetically
stabilized compared with Hu-TTR as seen by its significantly
slower dissociation/unfolding kinetics. Tetramer disassembly was
measured by resveratrol binding fluorescence; unfolding was
measured by tryptophan fluorescence.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2008,
283,
2098-2107)
copyright 2008.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Zrimi,
A.Ng Ling,
E.Giri-Rachman Arifin,
G.Feverati,
and
C.Lesieur
(2010).
Cholera toxin B subunits assemble into pentamers--proposition of a fly-casting mechanism.
|
| |
PLoS One,
5,
e15347.
|
 |
|
|
|
|
 |
J.N.Buxbaum
(2009).
Animal models of human amyloidoses: are transgenic mice worth the time and trouble?
|
| |
FEBS Lett,
583,
2663-2673.
|
 |
|
|
|
|
 |
L.Cendron,
A.Trovato,
F.Seno,
C.Folli,
B.Alfieri,
G.Zanotti,
and
R.Berni
(2009).
Amyloidogenic potential of transthyretin variants: insights from structural and computational analyses.
|
| |
J Biol Chem,
284,
25832-25841.
|
 |
|
|
|
|
 |
P.Prapunpoj,
and
L.Leelawatwattana
(2009).
Evolutionary changes to transthyretin: structure-function relationships.
|
| |
FEBS J,
276,
5330-5341.
|
 |
|
|
|
|
 |
T.Mairal,
J.Nieto,
M.Pinto,
M.R.Almeida,
L.Gales,
A.Ballesteros,
J.Barluenga,
J.J.Pérez,
J.T.Vázquez,
N.B.Centeno,
M.J.Saraiva,
A.M.Damas,
A.Planas,
G.Arsequell,
and
G.Valencia
(2009).
Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.
|
| |
PLoS ONE,
4,
e4124.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |